In Sweden (with 9 million inhabitants), more than 20,000 elective foot and ankle surgical procedures were done annually during the period 2007--2009. There is a need for structured evaluation of disability before and after surgery. Subjective aspects of patients' symptoms should be one part of this evaluation, preferably captured by patient-reported outcome measures (PROMs). Apart from being valid and reliable, such a measure must also be simple, patient-friendly, and usable in all types of foot and ankle disorders ([@CIT0027]). There are several PROMs, either generic or foot- and ankle-specific questionnaires, but there is no gold standard. The generic questionnaires short form 36 (SF-36) ([@CIT0028], [@CIT0021]) and EuroQol (EQ-5D) ([@CIT0013]) are useful for evaluation of general health, but they are of less value for region-specific disability. The foot and ankle outcome score (FAOS), a foot- and ankle-specific questionnaire ([@CIT0024]), is only validated for ankle instability and a limited number of foot disorders, and is therefore not optimal for use in registries covering all kinds of disabilities of the foot and ankle. The FAOS contains 42 questions; this is too long. The American Orthopaedic Foot and Ankle Society score (AOFAS) ([@CIT0016]), another well-known and well-used region-specific score, includes a clinical examination and is therefore not a PROM. Based on the validated Oxford-12 questionnaire for total hip replacement ([@CIT0009]), the New Zealand National Joint Registry constructed a patient-reported ankle questionnaire ([@CIT0015]). This questionnaire has been culturally adapted and translated into Swedish, and then called the self-reported foot ankle score (SEFAS). In the first validation study, SEFAS was found to be a valuable PROM in patients with osteoarthritis (OA) or inflammatory arthritis in the ankle joint ([@CIT0008]). But SEFAS must also be validated in patients with forefoot, midfoot, and hindfoot disorders---and also in patients with other diagnoses of the ankle joint---before it can be used in a national registry. We evaluated the psychometric properties of SEFAS in terms of reliability, validity, and responsiveness in patients with forefoot, midfoot, hindfoot, and ankle disorders.

Patients and methods {#ss1}
====================

The self-reported foot and ankle score (SEFAS) {#ss2}
----------------------------------------------

SEFAS is a foot- and ankle-specific questionnaire based on the New Zealand total ankle questionnaire ([@CIT0015]). The latter was translated into Swedish, culturally adapted, and validated with good results in patients with OA or inflammatory disease of the ankle joint ([@CIT0008], [www.swedankle.se](www.swedankle.se)). The questionnaire contains 12 items with 5 response options. The questionnaire covers different constructs, which are not reported separately in subscales. The most important of these constructs are pain, function, and limitation of function. Each of the 12 multiple-choice questions scores from 0 to 4 where a sum of 0 points represents the most severe disability and 48 represents normal function. In cases of incomplete questionnaires in the SEFAS, we used the following approach: (1) when results from 2 or more questions were missing, the questionnaire was disregarded; (2) when the result from 1 question was missing, the mean result of the remaining 11 questions was used; (3) when the patients gave 2 answers for 1 question, the worse outcome was recorded; and (4) when the patients had put a mark between 2 answers, the worse outcome was recorded.

The foot and ankle outcome score (FAOS) {#ss3}
---------------------------------------

FAOS is a region-specific score calculated from a patient-reported 42-item questionnaire developed for foot- and ankle-related disability ([@CIT0024]). The FAOS covers 5 separately reported dimensions: (1) pain, (2) other symptoms, (3) activities of daily living (ADL), (4) function in sport and recreation, and (5) ankle-related quality of life (QoL). Each question is rated on a scale from 0 to 4. A score is calculated for each subscale, after which raw scores for each subscale are transformed to a scale ranging from 0 to 100 and presented graphically as the FAOS profile.

The Short Form 36 (SF-36) score {#ss4}
-------------------------------

SF-36 is a validated generic score calculated from a questionnaire that contains 36 items ([@CIT0028], [@CIT0021]). The score was developed for measurement of health-related quality of life, and the questionnaire is widely used for evaluation of patients with a variety of different diseases, including musculoskeletal disorders. The SF-36 measures 8 different dimensions of health.The minimum possible score of each dimension is 0 points and the maximum possible score is 100 points.

The EuroQol (EQ-5D) score {#ss5}
-------------------------

The EQ-5D is a generic patient-reported questionnaire developed for measurement of health outcome and quality of life ([@CIT0013]), and it is applicable to a wide range of health conditions and treatments. The EQ-5D has 2 parts---the EQ-5D questionnaire and the EQ visual analog scale (EQ VAS). The questionnaire covers 5 different dimensions: (1) mobility, (2) self-care, (3) usual activities, (4) pain and discomfort, and (5) anxiety/depression. We used the UK EQ-5D Tariff for transformation of the results to a single summary index, ranging from --0.56 to 1.0. The EQ VAS assesses an individual\'s rating of their current state of health on a vertical visual analog scale, ranging from 0 to 100.

Patients {#ss6}
--------

To answer the 4 different questionnaires, we had a group of consecutively recruited patients. We recruited 96 women and 22 men with forefoot disorders and a median age of 57 (16--87) years, and 59 women and 47 men with midfoot, hindfoot or ankle disorders and a median age of 55 (18--81) years. They had all been scheduled for foot or ankle surgery at the orthopedic departments in Kalmar or Eksjö, Sweden, during the period January 1, 2011 to January 31, 2013 ([Table 1](#T1){ref-type="table"}). Only 9 of the patients were planned for surgery of the midfoot, and for that reason we included them in the hindfoot/ankle group. In 19 patients with a hindfoot/ankle disorder, we also measured the time the patients used to complete the different questionnaires. In 37 of the patients with forefoot disorders and 52 of the patients with hindfoot/ankle disorders, we provided the questionnaires twice before surgery with a week apart, in order to test reliability and agreement. In 68 of the patients with forefoot disorders and 74 of the patients with hindfoot/ankle disorders, we also provided the questionnaires 6 months after surgery in order to evaluate responsiveness.

###### 

Patient data

                                Patients with forefoot disorders   Patients with midfoot/hindfoot/ankle disorders
  ----------------------------- ---------------------------------- ------------------------------------------------
  No.                           118                                105
  Age                                                              
   Median (range)               57 (16--87)                        55 (18--81)
  Sex                                                              
   Male (%)                     22 (19%)                           46 (44%)
   Female (%)                   96 (81%)                           59 (56%)
  Height, cm                                                       
   Mean (SD)                    169 (8.6)                          172 (10.8)
  Weight, kg                                                       
   Mean (SD)                    74 (13.4)                          84 (15.6)
  Diagnosis                                                        
   Arthritis                    4                                  33
   Achilles tendon disorders    0                                  12
   Flatfoot                     0                                  26
   Cavovarus/neurological       2                                  21
   Great toe disorders          91                                 0
   Lesser toe disorders         17                                 0
   Others                       4                                  13
  Surgery                                                          
   Arthrodesis                  10                                 38
   Calcaneal osteotomy          0                                  32
   Tendon surgery               0                                  18
   Osteotomy first metatarsal   77                                 1
   Surgery in lesser toes       18                                 0
   Tendon transfers             1                                  9
   Others                       11                                 7

Informed written consent was obtained from the participants. The study was approved by the ethics committee of Lund University, Sweden (2009/698) and was performed in accordance with the Declaration of Helsinki.

Evaluation of the scores {#ss7}
------------------------

Validity is the degree to which a score actually measures what it is intended to measure.

Content validity evaluates the extent to which the concepts of interest are represented by the different items in the questionnaire, and it is also an assessment of the patients' perceptions of the relevance of the questionnaire. To examine the content validity, we applied the general recommendations for creation of questionnaires ([@CIT0029]). First, the questions were discussed in a group of orthopedic surgeons, physiotherapists, and nurses. Then we let a group of patients discuss the different questions, one by one, together with a research nurse. After adopting the suggestions from the groups, minor changes in the text of the questionnaire were made; we did not have to exclude or add any questions. The questionnaire was then given to 10 patients with different hindfoot disabilities. None of the volunteers reported any difficulty in understanding or completing the questionnaire, and no further changes were made. Finally, we let 40 patients with forefoot disorders grade each question from 1 to 3 where 1 point represented an unimportant question, 2 an important question, and 3 a very important question to examine the relevance of the questions, in order to evaluate content validity. The questions with an average score ≥ 2 were considered relevant, with good content validity.

Construct validity concerns the extent to which a score relates to other scores ([@CIT0029], de [@CIT0012]). In the absence of a gold standard, the validity in this study was expressed in terms of construct validity, calculated with Spearman's correlation coefficient and Pearson's correlation coefficient, when SEFAS was compared to FAOS, SF-36 and EQ-5D. According to recommendations from [@CIT0029], construct validity was assessed by testing hypotheses concerning correlations between the scores specified in advance. We defined the construct validity as being good if \> 75% of our own defined hypotheses could be confirmed.

For convergent validity, we formulated 5 hypotheses. When comparing SEFAS against the FAOS subscales pain, ADL, and QoL, and also the SF-36 subscales bodily pain (BP) and physical functioning (PF), the correlation coefficient should be ≥ 0.60 for a strong correlation (de [@CIT0012]). We also hypothesized that SEFAS would show stronger correlation with these 3 FAOS subscales than with the 2 SF-36 subscales.

For discriminant validity, we formulated 3 hypotheses. When comparing SEFAS against SF-36 GH, RE, and mental health (MH), the correlation coefficient should be ≤ 0.30 for a weak correlation (de [@CIT0012]). We also hypothesized that for all the other comparisons between SEFAS and SF-36, the EQ-5D, and FAOS, other subscales should show correlation coefficients between 0.30 and 0.60 (moderate correlation). For evaluation of the construct of major interest, i.e. pain and function in SEFAS, we related the pain-specific and function-specific questions separately to specific subscales in the other scores.

Floor and ceiling effects are considered to be present when more than 15% of the individuals reach the highest or lowest possible numeric value of a score. A high floor or ceiling effect could make it difficult to measure changes after interventions such as surgery ([@CIT0029], [@CIT0030]).

Reliability shows the reproducibility of a score. We evaluated test-retest reliability by letting the patients complete the questionnaires twice: the first time about 1 week before surgery, and the second time on the day before or on the day of surgery, but always before the surgery. We used intra-class correlation coefficient (ICC) with a 2-way mixed model to evaluate test-retest reliability. The ICC is considered to be good at 0.70 and above ([@CIT0026]). However, reliability also includes internal consistency, as an estimate of the extent to which the specific questions within a score are correlated to each other. Cronbach's α (CA) was used to test internal consistency and the widely accepted cutoff for CA at 0.70 was used ([@CIT0026]).

Agreement involves the measurement error of a score. The 2 sets of questionnaires described above were used for the evaluation of agreement, and data was prepared as Bland-Altman plots, 1 plot for each group. These plots show the difference between the SEFAS score in the 2 questionnaires answered by the same patient. Intra-individual variability of the functional measures was expressed as standard error of a single determination (S~method~), and is shown together with the coefficient of variation (CoV in %) for all scores. The formula used was S~method~ = √ (Σdi 2 / (2n)), where di is the difference between the i^th^ paired measurement and n is the number of differences.

Responsiveness is the ability of a score to detect changes due to an intervention such as surgery. We included all patients who had completed the questionnaires before and 6 months after surgery. To test responsiveness, we used effect size (ES) and standardized response mean (SRM). ES is calculated as the difference between the means before and after treatment divided by the standard deviation (SD) of the same measure before treatment. [@CIT0007] defined an ES of 0.20 as small, 0.50 as moderate, and of 0.80 or greater as large. SRM is calculated as the difference between the means before and after treatment divided by the SD of the change. SRM values are generally lower than the corresponding ES values ([@CIT0018]).

Statistics {#ss8}
----------

The statistics related to validity, reproducibility, reliability, agreement, and responsiveness are described under each paragraph above. For the construct validity calculations we used both Spearman's and Pearson's correlation equation.

We calculated the 95% confidence interval (CI) for the correlations according to Fisher's z-transformation. We calculated the confidence intervals for ES and SRM according to the method described by [@CIT0003]. These confidence intervals were calculated assuming a normal distribution. All comparisons were done separately for patients with forefoot disorders and patients with hindfoot/ankle disorders. We used SPSS software version 17.0.

Results {#ss9}
=======

The 40 patients who estimated the relevance of the 12 questions rated them between 2 and 2.8, with a mean value of 2.6, indicating good content validity. The 19 patients with whom the time to complete the questionnaires was measured completed SEFAS twice as quickly as they completed FAOS and SF-36, but not as fast as they completed EQ5D ([Table 3](#T3){ref-type="table"}).

Regarding construct validity, SEFAS mainly measures pain and function, with the strongest correlations being found between SEFAS and the subscales in FAOS and SF-36 that measure these constructs. In patients with forefoot and hindfoot/ankle disorders, 80% of our predefined hypotheses were confirmed, and there were strong correlations between SEFAS and 4 of the 5 subscales in FAOS, with correlation coefficients higher than 0.60, and also between SEFAS and SF-36 subscales BP and PF. The correlations between SEFAS and SF-36 GH, SF-36 RE, and SF-36 MH were weak in patients with forefoot disability and moderate in patients with hindfoot/ankle disability, with correlation coefficients of ≤ 0.30 and 0.30--0.60 respectively. The correlation coefficients between the pain-specific questions in SEFAS and the FAOS subscale pain and SF-36 BP were 0.8 and 0.7, respectively, in forefoot patients and 0.8 and 0.7, respectively, in hindfoot/ankle patients. In forefoot patients, the correlation coefficients between the function-specific questions in SEFAS on the one hand and FAOS subscale ADL and SF-36 PF on the other were 0.7 and 0.7, respectively, and in hindfoot/ankle patients the corresponding values were 0.6 and 0.7. None of the patients reached the highest or lowest numeric values in the SEFAS score, indicating that there were no floor or ceiling effects ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

###### 

Validity, reliability, and measurement error of 4 different questionnaires evaluating patients with forefoot disorders. Correlation analyses compared SEFAS with the other questionnaires. Data are presented as mean with 95% confidence interval (CI), as standard deviation (SD), or as percentage (%). Agreement is presented as S~method~ with CV% witihin brackets

  Questionnnaires              Validity            Floor and ceiling effects (%)   Test mean (SD)   Reliability   Cronbach\'s α   Agreement                   
  ---------------------------- ------------------- ------------------------------- ---------------- ------------- --------------- -------------------- ------ ------------
  No.                          118                 118                             118              37            37              37                   118    37
  SEFAS                        \_                  \_                              0                29 (8)        30 (8)          0.92 (0.85--0.96)    0.84   2.3 (8%)
  FAOS                                                                                                                                                        
   Pain                        0.82 (0.75--0.87)   0.83 (0.76--0.88)               3                66 (21)       70 (19)         0.91 (0.84--0.95)    0.91   6.6 (10%)
   Symptoms                    0.64 (0.52--0.74)   0.63 (0.51--0.73)               8                79 (15)       83 (15)         0.81 (0.67--0.90)    0.78   6.9 (9%)
   ADL                         0.75 (0.66--0.82)   0.75 (0.65--0.82)               8                78 (22)       81 (19)         0.92 (0.85--0.96)    0.97   6.1 (8%)
   Sport/Recreation            0.52 (0.37--0.64)   0.52 (0.37--0.64)               12               53 (28)       48 (28)         0.81 (0.66--0.90)    0.89   12.4 (25%)
   Quality of life             0.75 (0.66--0.82)   0.74 (0.65--0.81)               2                44 (20)       46 (21)         0.79 (0.62--0.88)    0.81   9.4 (21%)
  EQ-5D                        0.57 (0.43--0.68)   0.60 (0.47--0.71)               15               0.7 (0.3)     0.7 (0.2)       0.72 (0.51--0.85)    0.52   0.1 (19%)
  Visual analog scale (VAS)    0.41 (0.25--0.55)   0.46 (0.30--0.59)               4                72 (20)       73 (16)         0.92 (0.85--0.96)    --     4.6 (6%)
  SF-36                                                                                                                                                       
   Physical functioning (PF)   0.69 (0.58--0.78)   0.72 (0.62--0.80)               4                66 (23)       66 (20)         0.85 (0.73--0.92)    0.88   8.1 (12%)
   Role limitations,                                                                                                                                          
   physical (RP)               0.43 (0.27--0.57)   0.44 (0.28--0.57)               58               64 (41)       64 (42)         0.82 (0.67--0.90)    0.86   16.6 (26%)
   Bodily pain (BP)            0.71 (0.61--0.79)   0.73 (0.63--0.80)               3                46 (18)       49 (18)         0.82 (0.68--0.91)    0.84   7.9 (17%)
   General health (GH)         0.27 (0.09--0.43)   0.31 (0.13--0.46)               7                77 (17)       78 (19)         0.74 (0.53--0.86)    0.81   8.9 (11%)
   Vitality (VT)               0.48 (0.33--0.61)   0.52 (0.37--0.64)               2                62 (23)       69 (19)         0.86 (0.73--0.93)    0.82   9.1 (14%)
   Social functioning (SF)     0.40 (0.24--0.54)   0.39 (0.22--0.53)               50               88 (19)       88 (19)         0.76 (0.58--0.87)    0.80   9.3 (11%)
   Role limitation,                                                                                                                                           
   emotional (RE)              0.19 (0.01--0.36)   0.18 (--0.01--0.35)             74               90 (24)       87 (30)         0.66 ( 0.42--0.81)   0.78   13.0 (15%)
   Mental health (MH)          0.26 (0.08--0.42)   0.25 (0.07--0.41)               7                80 (18)       82 (17)         0.90 (0.82--0.95)    0.82   5.8 (7%)

###### 

Validity, reliability, and measurement error of 4 different questionnaires evaluating patients with hindfoot or ankle disorders. Correlation analyses compared SEFAS and the other questionnaires. The time it took to complete the questionnaires is presented for the different questionnaires. Data are presented as mean with 95% confidence interval (CI), as standard deviation (SD), or as percentage (%). Agreement is presented as S~method~ with CV% witihin brackets

  Questionnnaires                    Time(s)                               Validity            Floor and ceiling effects (%)   Test mean (SD)   Reliability   Cronbach\'s α       Agreement                        
  ---------------------------------- ------------------------------------- ------------------- ------------------------------- ---------------- ------------- ------------------- ------------------- ------------ ------------
  No.                                19                                    106                 106                             106              52            52                  52                  106          52
  SEFAS                              158                                   --                  --                              0                19 (9)        20 (9)              0.93 (0.88--0.96)   0.86         2.4 (13%)
  FAOS                               394                                                                                                                                                                           
   Pain                                                                    0.82 (0.75--0.87)   0.83 (0.76--0.88)               2                51 (25)       49 (25)             0.92 (0.87--0.96)   0.93         7.0 (14%)
   Symptoms                                                                0.65 (0.52--0.75)   0.70 (0.58--0.78)               1                51 (25)       50 (26)             0.92 (0.87--0.95)   0.80         7.1 (14%)
   ADL                                                                     0.68 (0.56--0.77)   0.71 (0.59--0.79)               4                59 (23)       57 (23)             0.92 (0.86--0.95)   0.97         6.8 (12%)
   Sport/Recreation                                                        0.62 (0.49--0.73)   0.62 (0.48--0.72)               34               18 (20)       20 (24)             0.67 (0.72--0.90)   0.85         12.7 (67%)
   Quality of life                                                         0.67 (0.55--0.76)   0.67 (0.54--0.76)               15               22 (15)       25 (17)             0.83 (0.72--0.90)   0.74         6.6 (28%)
  EQ-5D                              95 **[^a^](#T3-F1){ref-type="fn"}**   0.59 (0.45--0.70)   0.53 (0.37--0.66)               7                0.5 (0.3)     0.5 (0.3)           0.62 (0.41--0.76)   0.53         0.2( 35%)
  Visual analog scale (VAS)                                                0.51 (0.35--0.64)   0.52 (0.36--0.65)               3                63 (20)       62 (21)             0.91 (0.85--0.95)   --           6.1 (10%)
  SF-36                                                                                                                                                                                                            
   Physical functioning (PF)         388                                   0.65 (0.52--0.75)   0.64 (0.51--0.74)               4                41 (24)       40 (23)             0.89 (0.82--0.94)   0.90         7.8 (19%)
   Role limitations, physical (RP)                                         0.36 (0.18--0.52)   0.42 (0.25--0.57)               70               24 (36)       18 (31)             0.52 (0.28--0.69)   0.86         13.8 (61%)
   Bodily pain (BP)                                                        0.71 (0.60--0.79)   0.73 (0.63--0.81)               6                42 (24)       41 (27)             0.88 (0.81--0.93)   0.78         8.5 (20%)
   General health (GH)                                                     0.37 (0.19--0.53)   0.35 (0.17--0.51)               4                64 (24)       64 (22)             0.89 (0.81--0.93)   0.81         7.7 (12%)
   Vitality (VT)                                                           0.51 (0.35--0.64)   0.52 (0.37--0.65)               3                51 (25)       46 (26)             0.88 (0.79--0.93)   0.83         9.6 (20%)
   Social functioning (SF)                                                 0.50 (0.34--0.63)   0.51 (0.35--0.64)               32               69 (28)       68 (26)             0.88 (0.80--0.93)   0.86         9.3 (14%)
   Role limitation, emotional (RE)   0.37 (0.19--0.53)                     0.37 (0.19--0.53)   71                              59 (44)          58 (45)       0.79 (0.65--0.88)   0.86                18.1 (31%)   
   Mental health (MH)                                                      0.43 (0.26--0.58)   0.40 (0.23--0.55)               5                71 (20)       72 (20)             0.89 (0.81--0.94)   0.85         6.6 (9%)

**^a^** The time for completing EQ-5D questionnaire together with EQ VAS.

In forefoot patients, ICC for SEFAS was 0.92 (CI: 0.85--0.96) and in hindfoot/ankle patients it was 0.93 (CI: 0.88--0.96), indicating a high degree of reliability. For SEFAS in forefoot patients, Cronbach's α was 0.84 and in hindfoot/ankle patients it was 0.86---also supporting high reliability. The Bland-Altman plots showed clinically negligible systematic error (no bias). There were no major differences when comparing low and high SEFAS values, and the difference between 2 measurements stayed within ± 7 scoring units ([Figure](#F1){ref-type="fig"}). The measurement error analyses with the S~method~ also expressed as the coefficient of variation (CV) for all scores are presented in [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}. For SEFAS, in forefoot patients ES was 1.29 (CI: 0.95--1.63) and in hindfoot/ankle patients it was 1.05 (CI: 0.77--1.33). The corresponding values for SRM were 1.27 (CI: 0.93--1.61) and 0.99 (CI: 0.71--1.27), indicating high responsiveness ([Tables 4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}).

![Agreement in scores of patients with forefoot disorders (n = 37) and of patients with hindfoot or ankle disorders (n = 52) for SEFAS presented as Bland-Altman plots (Bland and Altman 1986). The solid line represents the mean value and the dotted lines show the limits for 2 standard deviations (SDs) above and below the mean value.](ORT-85-187-g001){#F1}

###### 

Pre- and postoperative values in 68 patients operated due to forefoot disorders, with responsiveness expressed as effect size (ES) and standardized response mean (SRM). Data are presented as mean with 95% confidence interval. Due to missing answers in some questionnaires, the numbers of fully filled questionnaires are presented in parentheses in the left-hand column (n)

  Questionnaire                      Preoperatively, mean   Postoperatively, mean   ES (95% CI)             SRM (95% CI)
  ---------------------------------- ---------------------- ----------------------- ----------------------- -----------------------
  SEFAS (n = 66)                     29                     38                      1.29 (0.95--1.63)       1.27 (0.93--1.61)
  FAOS (n = 68)                                                                                             
   Pain                              66                     87                      1.10 (0.78--1.42)       1.10 (0.82--1.46)
   Symptoms                          78                     84                      0.38 (0.12--0.64)       0.39 (0.13--0.65)
   ADL                               77                     92                      0.76 (0.50--1.02)       0.92 (0.65--1.19)
   Sport/Recreation                  47                     70                      0.82 (0.54--1.10)       0.77 (0.49--1.05)
   Quality of life                   44                     75                      1.48 (1.12--1.84)       1.32 (0.98--1.66)
  EQ-5D (n = 64)                     0.68                   0.87                    0.95 (0.60--1.30)       0.90 (0.56--1.24)
  VAS (n = 64)                       74                     81                      0.46 (0.21--0.71)       0.48 (0.23--0.73)
  SF-36 (n = 66)                                                                                            
   Physical functioning (PF)         65                     85                      0.94 (0.63--1.25)       0.75 (0.46--1.04)
   Role limitations, physical (RP)   58                     77                      0.44 (0.16--0.72)       0.42 (0.14--0.70)
   Bodily pain (BP)                  48                     77                      1.57 (1.17--1.97)       1.15 (0.79--1.51)
   General health (GH)               75                     77                      0.07 (--0.13 to 0.27)   0.09 (--0.11 to 0.29)
   Vitality (VT)                     65                     74                      0.45 (0.19--0.71)       0.43 (0.17--0.69)
   Social functioning (SF)           84                     91                      0.37 (0.14--0.60)       0.43 ( 0.19--0.67)
   Role limitation, emotional (RE)   84                     92                      0.27 (--0.01 to 0.55)   0.27 (--0.01 to 0.55)
   Mental health (MH)                81                     84                      0.15 (--0.09 to 0.39)   0.14 (--0.10 to 0.38)

###### 

Pre- and postoperative values in 68 patients operated on due to hindfoot or ankle disorders, with responsiveness expressed as effect size (ES) and standardized response mean (SRM). Data are presented as mean with 95% confidence interval. Due to missing answers in some questionnaires, the numbers of fully filled questionnaires are presented in the left-hand column (n)

  Questionnaire                      Preoperatively, mean   Postoperatively, mean   ES (95% CI)             SRM (95% CI)
  ---------------------------------- ---------------------- ----------------------- ----------------------- -----------------------
  SEFAS (n = 70)                     20                     29                      1.05 (0.77--1.33)       0.99 (0.71--1.27)
  FAOS (n = 74)                                                                                             
   Pain                              52                     72                      0.90 (0.66--1.14)       1.09 (0.83--1.35)
   Symptoms                          53                     64                      0.48 (0.27--0.69)       0.57 (0.35--0.79)
   ADL                               60                     77                      0.85 (0.62--1.08)       1.04 (0.79--1.29)
   Sport/Recreation                  20                     35                      0.70 (0.44--0.96)       0.57 (0.32--0.82)
   Quality of life                   22                     46                      1.57 (1.24--1.90)       1.18 (0.89--1.47)
  EQ-5D (n = 72)                     0.54                   0.69                    0.57 (0.28--0.86)       0.50 (0.21--0.79)
  VAS (n = 67)                       65                     72                      0.34 (0.06--0.62)       0.30 (0.02--0.58)
  SF-36 (n = 73)                                                                                            
   Physical functioning (PF)         40                     56                      0.73 (0.51--0.95)       0.83 (0.60--1.06)
   Role limitations, physical (RP)   26                     45                      0.51 (0.24--0.78)       0.42 (0.16--0.68)
   Bodily pain (BP)                  41                     57                      0.73 (0.47--0.99)       0.62 (0.37--0.87)
   General health (GH)               68                     68                      0.02 (--0.15 to 0.19)   0.03 (--0.14 to 0.20)
   Vitality (VT)                     54                     62                      0.35 (0.15--0.55)       0.45 (0.25--0.65)
   Social functioning (SF)           71                     78                      0.24 (0.02--0.46)       0.27 (0.05--0.49)
   Role limitation, emotional (RE)   57                     68                      0.24 (0.02--0.46)       0.25 (0.03--0.47)
   Mental health (MH)                74                     78                      0.20 (0.00--0.40)       0.24 (0.04--0.44)

Discussion {#ss10}
==========

We found that SEFAS has good validity, reliability, and responsiveness when evaluating patients with forefoot disorders and hindfoot/ankle disorders. The questionnaire---which has already been validated in patients with ankle OA and inflammatory disease in the ankle joint ([@CIT0008])---can now also be recommended as a valuable PROM when evaluating patients with different disorders of the foot and ankle. As SEFAS can be completed in a shorter time than FAOS and SF-36, it is more attractive to patients.

Several psychometric criteria must be fulfilled before a questionnaire can be rated as having good validity ([@CIT0004], [@CIT0029]). We found that validity for SEFAS was comparable or better than that for the other questionnaires evaluated. When comparing SEFAS and the region-specific FAOS, we found strong correlations in all of the FAOS subscales, except the subscale Sport and Recreation. The correlation between SEFAS and the FAOS subscale for Sport and Recreation was also low for the ankle in our previous study ([@CIT0008]), suggesting that FAOS captures sports-specific deficits better whereas SEFAS may reflect everyday activity better. We also found convergent validity when comparing SEFAS with pain- and function-related questions in SF-36. For the forefoot, there was (as hypothesized) divergent validity when we compared SEFAS to general health-related questions, but in hindfoot/ankle patients the correlations were moderate. One explanation for this would be that patients with neurological disorders, in whom general and mental health is more affected, were in this group. Finally, we found stronger correlations between SEFAS and EQ-5D than we had hypothesized, and the reason for this could be that pain is decisive in this score. In our previous study, we also found high correlations when comparing SEFAS to EQ-5D ([@CIT0008]).

To be able to capture changes in subjective symptoms, the answer to each question in a PROM must be translatable into a numeric score with the potential to increase if the patient gets better (as after surgery) or to decrease if he or she gets worse. To capture any changes in severity of symptoms, floor and ceiling effects should be minimized. Initially, FAOS was validated for ankle ligament reconstructions ([@CIT0024]). Recently, it was also validated for hallux valgus patients by [@CIT0006], who found ceiling effects for the subscales ADL and Sports and Recreation. We also found floor and ceiling effects for FAOS in the subscale Sport and Recreation, and in the subscales RP, SF, and RE of SF-36. The lack of floor or ceiling effects in SEFAS speaks in favor of this questionnaire.

SEFAS had good test-retest reliability, with an ICC of \> 0.70 both in patients with forefoot disorders and in those with hindfoot/ankle disorders. The internal consistency was also good, with Cronbach's α values of 0.83 in patients with forefoot disorders and 0.86 in patients with hindfoot/ankle disorders. In the ideal questionnaire, each question should capture 1 specific deficit because 2 or more questions capturing the same deficit would only mean unnecessary work for the patient without providing any new information. The Cronbach's α values for SEFAS indicated that each question actually captures different deficits, i.e. Cronbach's α was not too high.

Responsiveness in the region-specific FAOS and SEFAS was better than in the generic SF-36 and EQ-5D. FAOS has recently been reported to have low responsiveness for the subscales ADL and Sports and Recreation in patients with hallux valgus ([@CIT0006]), and for the subscales ADL, Symptoms, and Sports and Recreation in patients with acquired flatfoot deformity ([@CIT0019]). For SEFAS, the responsiveness was high for all types of patients and we even found higher ES and SRM in patients with forefoot disability than in patients with hindfoot/ankle disability. The reason for this is probably that patients who have undergone surgery for forefoot disorders have reached full recovery after 6 months, while patients with hindfoot/ankle surgery---which is known to have longer recovery periods---have not. It would therefore have been preferable with an even longer follow-up period for the responsiveness analysis. Even so, an ES of \> 1.0 in both the forefoot patients and hindfoot/ankle patients indicates that SEFAS is very capable of capturing changes in symptoms after foot and ankle surgery.

There are several foot- and ankle-specific questionnaires. The FAOS, a questionnaire translated into several languages ([@CIT0014]), has been validated for patients with ankle ligament reconstructions ([@CIT0024]), with hallux valgus ([@CIT0006]), and with acquired flatfoot deformity ([@CIT0019]). The high ceiling effects and low responsiveness in some of the subscales in FAOS make it less usable. The visual analog scale of the foot and ankle (VAS FA) is a validated German questionnaire that has also been translated into English and that shows good correlation with SF-36 ([@CIT0023]). However, since to our knowledge the reliability, content validity, and responsiveness have never been reported, the questionnaire cannot be considered to be a fully validated PROM.

The foot function index (FFI) ([@CIT0005]) is another PROM; it was initially validated in patients with rheumatoid arthritis. The FFI has been revised, giving several validated versions---a concern discussed by [@CIT0020] in a review of outcome instruments for total ankle arthroplasties. [@CIT0001] also found high ceiling effects for the FFI, which is a disadvantage. The Manchester-Oxford foot questionnaire (MOXQ) is a 16-item well-validated questionnaire with 3 scales. When we presented the SEFAS data for the ankle joint, MOXQ was only validated for hallux valgus ([@CIT0010]), but the questionnaire has now also been validated with good results for other foot and ankle disorders ([@CIT0011]). However, the MOXQ has not been translated and validated in Swedish, and can therefore not be used in a Swedish national registry.

By far the most used score is the AOFAS ([@CIT0016], [@CIT0017], [@CIT0022]), but this score has been questioned ([@CIT0025], [@CIT0002]). Also, the AOFAS involves 4 different questionnaires depending on which region of the foot and ankle has to be evaluated, and the score requires a time- and resource-consuming clinical examination. Because of this, the AOFAS cannot be used as a PROM.

The strength of our study was the structural evaluation of a variety of factors such as the reliability, validity, and responsiveness of SEFAS compared to those of other established foot- and ankle-specific and generic questionnaires. Furthermore, the inclusion of a variety of diagnoses and surgical procedures also increased the value of the study. It would, however, have been of advantage to include patients with acute foot and ankle disorders, with separate evaluations of hindfoot and ankle disorders, of specific diagnoses, of the forefoot disorders in different subgroups, and of specific surgical procedures. However, collection of large enough groups for subgroup analyses is difficult and is probably not possible before the questionnaire is used in a registry. Another limitation of our study was that the responsiveness analyses were done only once, and already after 6 months. It would have been advantageous to follow responsiveness for a longer time.

We conclude that SEFAS is a patient-reported questionnaire with good psychometric properties for evaluation of patients with different disorders and surgical procedures of the forefoot, the hindfoot, and the ankle joint. It is a PROM that can be used in national foot and ankle registries.
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